Открытое овальное окно и эмболический криптогенный инсульт

АА Кулеш, ВВ Шестаков - Неврология, нейропсихиатрия …, 2019 - cyberleninka.ru
В статье рассмотрена актуальная проблема криптогенного инсульта и открытого
овального окна (ООО). Освещены вопросы патогенеза и роль парадоксальной эмболии …

Cardioembolic stroke: mechanisms and therapeutics

DC Sacchetti, KL Furie, S Yaghi - Seminars in neurology, 2017 - thieme-connect.com
Cardioembolic stroke accounts for nearly 30% of all known stroke mechanisms. This
percentage may be underestimated, however, when considering the large proportion of …

Emerging risk factors for recurrent vascular events in patients with embolic stroke of undetermined source

Y Ueno, K Yamashiro, R Tanaka, T Kuroki, K Hira… - Stroke, 2016 - Am Heart Assoc
Background and Purpose—Underlying embolic causes diagnosed by transesophageal
echocardiography could be implicated in mechanisms of embolic stroke of undetermined …

Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis

F Angelini, F Fortuni, G Tsivgoulis, G Agnelli… - … Drugs and Therapy, 2021 - Springer
Purpose Patients with patent foramen ovale (PFO) and cryptogenic ischemic stroke (CS) are
at risk for stroke recurrence. The optimal antithrombotic strategy in patients who undergo …

Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis

XL Zhang, LN Kang, L Wang, B Xu - BMC cardiovascular disorders, 2018 - Springer
Background Patent foramen ovale (PFO) closure has emerged as a secondary prevention
option in patients with PFO and cryptogenic stroke. However, the comparative efficacy and …

Aspirin or anticoagulation after cryptogenic stroke with patent foramen ovale: systematic review and meta-analysis of randomized controlled trials

M Romoli, D Giannandrea, P Eusebi, LM Cupini… - Neurological …, 2020 - Springer
Introduction Since closure has restrictive eligibility criteria, the vast majority of patients with
cryptogenic stroke and patent foramen ovale (PFO) receive medical treatment. However, the …

Meta-analysis of randomized controlled trials on patent foramen ovale closure versus medical therapy for secondary prevention of cryptogenic stroke

A Smer, M Salih, TM Haddad, R Guddeti… - The American Journal of …, 2018 - Elsevier
The optimal management of patients with cryptogenic stroke (CS) and patent foramen ovale
(PFO) remains controversial. We conducted a meta-analysis to assess the effect of PFO …

Patent foramen ovale closure versus medical therapy after cryptogenic stroke: An updated meta-analysis of all randomized clinical trials

B Kheiri, A Abdalla, M Osman, S Ahmed… - Cardiology …, 2019 - journals.viamedica.pl
Background: Cryptogenic strokes can be attributed to paradoxical emboli through patent
foramen ovale (PFO). However, the effectiveness of PFO closure in preventing recurrent …

Antithrombotic management of ischemic stroke

KL Sloane, EC Camargo - Current treatment options in cardiovascular …, 2019 - Springer
Purpose of review Ischemic stroke describes a condition in which inadequate blood flow
leads to lack of oxygenation to the brain tissue and ensuing neuronal death. There are …

Patent foramen ovale closure versus medical therapy for cryptogenic stroke: meta-analysis of randomised trials

TKM Wang, MTM Wang, P Ruygrok - Heart, Lung and Circulation, 2019 - Elsevier
Background Patent foramen ovale (PFO) is a common anatomic variant associated with
cryptogenic stroke. Percutaneous PFO closure in these patients to prevent recurrent …